To date, there is little evidence showing LXR inhibition direct activates NLRP3, however, LXR inhibition has been shown to influence NLRP3 by causing cholesterol metabolism disorder or mitochondrial injury and oxidative stress imbalance. The gene discussed is NLRP3; the disease is cholesterol metabolism disease.